A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the treatment of advanced non-small cell lung cancer.

Xiao-Yan SiJinwan WangYing ChengJianhua ShiLiying CuiHelong ZhangYunchao HuangWei LiuLei ChenJiang ZhuShucai ZhangWei LiYan SunHanping WangXiaotong ZhangMengzhao WangLin Yang Li Zhang

Published in: Therapeutic advances in medical oncology (2020)

chinadrugtrials.org.cn identifier: CTR20160395.

Keyphrases

phase iii
double blind
advanced non small cell lung cancer
placebo controlled
open label
clinical trial
phase ii
epidermal growth factor receptor
study protocol
squamous cell carcinoma
lymph node metastasis
radiation therapy
replacement therapy
combination therapy
smoking cessation